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Abstract
It is well-established that COPD patients have a burden of vascular disease that 
cannot be fully-explained by smoking history but the mechanistic links between 
atherosclerosis and pulmonary disease in COPD patients are not well-understood. 
Moreover, in ex-smokers without symptoms or other evidence of COPD, subclinical 
pulmonary and vascular disease, although potentially present, has not been described 
or evaluated. Hence our aim was to use sensitive three-dimensional (3D) pulmonary 
and carotid imaging to quantify pulmonary airway/parenchyma abnormalities and 
atherosclerosis in ex-smokers without airﬂ ow limitation or symptoms consistent with 
COPD. We evaluated 61 subjects without airﬂ ow limitation including 34 never- (72  
6 years) and 27 ex-smokers (73  9 years), who provided written informed consent 
to spirometry, plethysmography, 3He magnetic resonance imaging (MRI) and carotid 
ultrasound (US) and, for ex-smokers alone, thoracic X-ray computed tomography 
(CT). Ex-smokers had signiﬁ cantly greater 3He ventilation defect percent (VDP  
7%, p  0.001) and carotid total plaque volume (TPV  250 mm3, p  0.002) than 
never-smokers, although there were no signiﬁ cant differences for spirometry or 
plethysmography, and CT airway and emphysema measurements were normal. There 
were univariate relationships for 3He VDP with carotid intima media thickness (IMT, 
r  0.42, p  0.004), TPV (r  0.41, p  0.006) and vessel wall volume (VWV, r  0.40, 
p  0.007). Multivariate models that included age, BMI, FEV1, DLCO and VDP showed 
that only VDP signiﬁ cantly predicted IMT (  0.41, p  0.001), VWV (  0.45, 
p  0.003) and TPV (  0.38, p  0.005). In summary, there was imaging evidence 
of mild airways disease and carotid plaque burden that were related and signiﬁ cantly 
greater in ex-smokers without airﬂ ow limitation than in never-smokers.
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Introduction
Cardiovascular disease is the single largest cause of hospitalization in patients 
with mild and moderate chronic obstructive pulmonary disease (COPD), 
and after lung cancer, the leading cause of death (1, 2). In addition, in COPD 
patients, there is a dose-response relationship for pulmonary structure- 
function abnormalities with carotid atherosclerosis (3–8), coronary artery 
calciﬁ cation (9–12) and vascular dysfunction (13–16). Although these studies 
have shown the presence of cardiovascular disease in patients with COPD that 
cannot be explained by smoking history alone (3, 4, 6–8, 17), the mechanisms 
by which cardiovascular disease may be accelerated in COPD are not clear, nor 
is our understanding of these relationships in early or milder subclinical stages. 
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Although the diagnosis and monitoring of COPD is 
mainly based on spirometry measurements of airﬂ ow 
obstruction (18, 19), such measurements cannot fully 
characterize the pathophysiological changes that occur 
in obstructive lung disease (20). Th ese include regional 
small-airways disease and microstructural changes in 
the terminal bronchi and parenchyma. In this regard, 
regional imaging measurements provided by hyper-
polarized 3He magnetic resonance imaging (MRI) are 
highly sensitive to pulmonary abnormalities in asymp-
tomatic ex-smokers (21, 22) and never-smokers with 
second-hand smoke exposure (23). Similarly, airway 
morphology and parenchyma density X-ray computed 
tomography (CT) measurements from the ECLIPSE (24) 
and COPDGene (25) studies showed the utility of CT 
phenotypes (26) for stratifying COPD patients (27–29). 
Cardiovascular disease, predominated by large ves-
sel atherosclerosis, is associated with obstructive lung 
disease (30, 31) that can be regionally and quantitatively 
evaluated using carotid ultrasound (US). Th e burden 
of atherosclerosis can be quantiﬁ ed (32) using carotid 
intima-media thickness (IMT) measurements and this 
is believed to reﬂ ect medial hypertrophy and intima 
abnormalities, and importantly, IMT correlates with 
cardiovascular outcomes (32, 33). In a similar manner, 
three-dimensional ultrasound (3DUS) carotid athero-
sclerosis measurements (34) of carotid wall and plaque 
abnormalities are sensitive predictors of cardiovascular 
risk (35–37) and in some patients, these provide a better 
estimate of plaque burden and risk than IMT alone (37). 
Th ere is a paucity of direct evidence relating  subclinical 
lung disease and atherosclerosis in otherwise healthy 
 ex-smokers. To provide a better understanding of the rela-
tionship between carotid atherosclerosis and pulmonary 
abnormalities common to ex-smokers with obstructive 
lung disease, our objective was to acquire highly sensi-
tive pulmonary and carotid 3D imaging measurements in 
never- and ex-smokers with normal pulmonary function. 
We hypothesized that quantitative 3D imaging pheno-
types would provide a way to tease out potential relation-
ships for early or mild sub-clinical emphysema or airways 
disease with atherosclerosis in subjects at risk. 
Methods
Study subjects
Ex-smokers (≥10 pack-year smoking history) without 
symptoms or a physician-diagnosis of COPD and nor-
mal spirometry (FEV1/FVC ≥ 70%) as well as never-
smokers (<1 pack-year smoking history) with no history 
of chronic respiratory or signiﬁ cant or uncontrolled 
cardiovascular disease between 50–90 years of age were 
recruited. Th ese subjects enrolled in response to adver-
tisements placed within the community and at local 
healthy ageing exercise and atherosclerosis prevention 
clinics. All subjects provided written informed consent 
to a protocol approved by a local research ethics board 
and Health Canada.
Spirometry and plethysmography
Spirometry, plethysmography and diﬀ using capacity of 
carbon monoxide (DLCO) measurements were performed 
according to the American Th oracic Society guidelines 
(19). An ndd EasyOne spirometer (ndd Medizintchnik 
AG, Zurich, Switzerland) was used to measure FEV1 and 
FVC. Whole body plethysmography was performed for 
lung volumes and DLCO measurements were recorded 
using a gas analyzer (MedGraphics Corporation, St. 
Paul, Minnesota, USA).
Image acquisition
High-resolution B-mode ultrasound (US) images were 
acquired (ATL HDI 5000; Philips, Bothel,  Washington, 
USA) as previously described (38) using a 50 mm 
L12-5 MHz transducer (frequency = 8.5 MHz,  Philips). 
Gain, focal points and time-depth compensation were 
optimized by the sonographer taking into consider-
ation neck size, carotid anatomy and tissue depth. 
Two dimensional images were reconstructed into a 3D 
volume as previously described (39, 40). MRI was per-
formed on a whole body 3.0 Tesla Discovery 750MR 
(General Electric Health Care, Milwaukee, Wisconsin, 
USA) MRI system. 1H and 3He MRI were performed as 
previously described (41) with the subject in an inspira-
tion breath-hold (FRC+1L). For ex-smokers only, com-
puted tomography (CT) was acquired within 10 minutes 
of MRI and at the same lung volume (FRC+1L) to ensure 
similar parenchymal distension in a method previously 
described (41).
Image analysis
Carotid IMT was measured from the longitudinal 
plane of the 3DUS volume using Prowin 24.0 software 
 (Medical Technologies International Inc., Palm Desert, 
California, USA) as previously described (42). Carotid 
total plaque volume (TPV) and vessel wall volume 
(VWV) were measured as previously described (43).
3He MRI ventilation defect percent (VDP) and appar-
ent diﬀ usion coeﬃ  cients (ADC) were measured using 
semi-automated segmentation generated using custom-
built software in MATLAB R2007b (Th e Math-works 
Inc., Natick, Massachusetts, USA) as previously described 
(44, 45). CT volumes were analyzed using Pulmonary 
Workstation 2.0 (PW2, VIDA Diagnostics Inc., Coralville, 
Iowa, USA). Pulmonary CT images were analyzed for 
airway dimensions including wall area percent (WA%), 
lumen area (LA) and standardized wall thickness of air-
ways with an inner perimeter of 10 mm (Pi10) (46). In 
addition, the relative area of the lung with CT attenuation 
values less than -950HU (RA950) and total airway count 
were also measured using PW2.
Statistics
Normality of data was tested using the Shapiro–Wilk 
test and when signiﬁ cant, the Mann-Whitney U-test for 
nonparametric data was performed using SPSS Statistics 
V20.0 (SPSS Inc, Chicago, Illinois, USA). Unpaired two 
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tailed t-test comparisons were performed using Graph-
Pad Prism V4.0 (GraphPad Software Inc, California, 
USA) and Welch’s correction used when the F-test for 
equal variances was signiﬁ cant. Th e Holm-Bonferroni 
correction (47) was performed for multiple unpaired 
t-test comparisons. Multiple regression analyses were 
performed in SPSS to determine the relationship 
between carotid US measurements with 3He MRI VDP 
and pulmonary function parameters. Partial correla-
tions were computed using SPSS. Multiple regression 
and  correlation models were adjusted for age, BMI and 
DLCO  since these parameters are established risk fac-
tors for cardiovascular and pulmonary diseases (8, 48). 
Results were considered signiﬁ cant when the probabil-
ity of  two-tailed type I error was less than 5% (p < 0.05) 
and summary data are presented as mean ± SD unless 
 otherwise indicated.
Results
As shown in Table 1, 61 subjects including 27 ex-smokers 
(73 ± 9 years, 18 male) and 34 never-smokers (72 ± 6 years, 
18 male) were evaluated. Except for BMI, (p = 0.001) there 
were no signiﬁ cant diﬀ erences between subject groups for 
demographic characteristics. 
Figure 1 shows 3He MRI center coronal slices and 
3DUS axial and longitudinal images for representative 
ex- and never-smokers. 3He MRI ventilation images show 
homogeneous ventilation in never-smokers, whereas 
there is heterogeneous signal intensity with visually obvi-
ous ventilation defects in ex-smokers. 3DUS axial images 
show carotid plaque that is qualitatively greater in the two 
ex-smokers. 
Quantitative results are provided in Figure 2 and 
Table 1 that show that the ex-smokers subgroup had sig-
niﬁ cantly greater TPV, (250 ± 200 mm3, p = 0.002) and 
3He MRI VDP, (7 ± 3%, p = 0.001) than never-smokers. 
No signiﬁ cant diﬀ erences were observed for VWV (p =
1.0), IMT (p = 0.11), ADC (p = 0.20) or FEV1 (p = 0.89). 
For ex-smokers, CT mean RA950 (1.5 ± 1.4%), airway wall 
thickness at an internal perimeter of 10 mm (Pi10, 4.1 ±
0.17 mm), WA% (61 ± 2%), and LA (17 ± 11 mm2) were 
within  normal range as previously published (49, 50).
Using previously established age-normalized values 
for IMT (51), 28 subjects (15 ex-smokers and 13 never-
smokers, 28/61 = 46%) exceeded the upper limit of 
normal for IMT and 33 subjects (12 ex-smokers and 21 
never-smokers, 33/61 = 54%) had normal IMT. As shown 
in Figure 3, subjects with abnormally elevated IMT had 
signiﬁ cantly greater VDP (p = 0.04) than subjects with 
normal IMT, but the two subgroups were not signiﬁ -
cantly diﬀ erent with respect to ADC (p = 0.06), FEV1%pred 
(p = 1.0) or DLCO%pred (p = 0.85).  CT measurements for the 
15 ex-smokers with abnormal IMT were not signiﬁ cantly 
diﬀ erent than ex-smokers with normal IMT for RA950 
(p = 0.96), WA% (p = 0.66) or LA (p = 0.63).
As shown in Figure 4, univariate Pearson correlations 
between 3He MRI VDP and carotid ultrasound mea-
surements revealed a moderate signiﬁ cant relationship 
for VDP with carotid IMT (r = 0.42, p = 0.004), TPV 
(r = 0.41, p = 0.006) and VWV (r = 0.40, p = 0.007). Mul-
tivariate regression models for IMT, VWV and TPV are 
provided in Table 2. VDP was a signiﬁ cant determinant 
of IMT (β = 0.41, p = 0.001), VWV (β = 0.45, p = 0.003) 
and TPV (β = 0.38, p = 0.005). For the ex-smokers alone, 
CT-derived measurements including RA950 and airway 
count, WA%, LA and Pi10 did not correlate with carotid 
US measurements of IMT, TPV and VWV.
Discussion
We tested the hypothesis that atherosclerosis and 
pulmonary structure-function measurements were 
signiﬁ cantly diﬀ erent in ex-smokers without airﬂ ow 
Table 1. Demographic, pulmonary function, thoracic CT and carotid ultrasound 
data for all study subjects
Ex-smokers
n = 27
Never-smokers
n = 34
Signiﬁ cance of 
Difference p∗
Age yrs (±SD)  73 (9)  72 (6) 1.0
Male n  18  18 –
BMI kg·m
–2 (±SD)  30 (3)  27 (3) 0.001
Pack years (±SD)  27 (18) – –
Years quit (±SD)  26 (6) – –
FEV1 %pred (±SD) 106 (16) 106 (18) 0.89
FVC %pred (±SD)  97 (13) 101 (17) 1.0
FEV1/FVC (±SD)  81 (7)  77 (5) 0.36
TLC %pred (±SD) 102 (14) 106 (15) 1.0
IC %pred (±SD) 107 (14) 107 (22) 1.0
RV %pred (±SD) 110 (26) 109 (29) 1.0
RV/TLC (±SD)  42 (7)  39 (13) 0.96
Raw%pred (±SD) 115 (72)  76 (34) 0.11
DLCO %pred (±SD)  83 (17)  87 (20) 1.0
ADC cm2/s (±SD) 0.29 (0.04)1 0.26 (0.03)2 0.20
VDP % (±SD)   7 (3)1 3 (2)2 0.001
IMT mm (±SD) 0.84 (0.10) 0.77 (0.09) 0.11
TPV mm3  (±SD) 250 (200)  60 (90) 0.002
VWV mm3 (±SD) 910 (190)3 890 (170)4 1.0
5th gen. WA% (±SD)  61 (2) – –
5th gen. LA mm2 (±SD)  17 (11) – –
Pi10 mm (±SD) 4.1 (0.17) – –
RA950 % (±SD) 1.5 (1.4) – –
Airway Count n (±SD) 127 (35)
BMI: Body mass index, FEV1: Forced expiratory volume in one second, FVC: Forced vital 
capacity, TLC: Total lung capacity, IC: Inspiratory capacity, RV: Residual volume, Raw: 
Airways resistance, DLCO: Diffusing capacity for carbon monoxide, ADC: Apparent 
diffusion coefﬁ cient, VDP: Ventilation defect percentage, IMT: Intima-media thickness, 
TPV: Total plaque volume, VWV: Vessel wall volume, 5th gen.: Fifth generation airway, 
WA%: Airway wall area percentage, LA: Airway lumen area, Pi10: Standardized wall 
thickness of airways with an inner perimeter of 10 mm, RA950: Relative area of the 
lung with attenuation values below –950HU, SD: Standard deviation, %pred: Percent 
of predicted value.
∗Data are Holm-Bonferroni corrected p-values for unpaired t-test comparisons 
1n = 26, 2n = 29, 3n = 22, 4n = 30.
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limitation or symptoms consistent with COPD than in 
never-smokers. We observed: 1) ex-smokers had sig-
niﬁ cantly greater carotid TPV and worse 3He VDP than 
never-smokers, but were not signiﬁ cantly diﬀ erent with 
respect to pulmonary function test measurements, 2) 
28 subjects including 15 ex- and 13 never-smokers with 
abnormally elevated IMT had signiﬁ cantly worse VDP 
but ADC, FEV1, DLCO and CT measurements were not 
diﬀ erent compared to subjects with normal IMT, 3) 3He 
VDP was signiﬁ cantly related to carotid atherosclerosis 
measurements (IMT, VWV and TPV) but pulmonary 
function tests were not, and 4), multivariate regression 
models showed that VDP, a measurement of small air-
way function, was the only signiﬁ cant determinant of 
carotid artery IMT, VWV and TPV.
In these older subjects without COPD, we observed, 
as expected, that spirometry and plethysmography 
measurements were not different in ex- and never-
smokers, but importantly 3He VDP was significantly 
worse for ex-smokers. This finding is concordant with 
previous findings in asymptomatic ex-smokers that 
showed significant differences in 3He MRI ventilation 
defects compared to never-smokers (22). Although 
we did not observe differences between subgroups 
for 3He MRI ADC, abnormally elevated 3He ADC has 
been previously reported in asymptomatic smokers 
Figure 1. Representative 3He MRI and 3DUS images for two never-smokers (S1 and S2) and two ex-smokers (S3 and S4). Never-smoker S1 is a 67-year-old female with 
FEV1 = 120%, FEV1/FVC = 0.77, 
3He MRI VDP = 3%, TPV = 20 mm3 and IMT = 0.79 mm. Never-smoker S2 is a 68-year-old male with FEV1= 93%, FEV1/FVC = 0.79, 
3He MRI 
VDP = 2%, TPV = 30 mm3 and IMT = 0.73 mm. Ex-smoker S3 is a 79-year-old female with FEV1 = 88%, FEV1/FVC = 0.71, VDP = 8%, TPV = 500 mm
3 and IMT = 0.94 mm. 
Ex-smoker S4 is a 85-year-old male with FEV1 = 139%, FEV1/FVC = 0.79, VDP = 8%, TPV = 340 mm
3 and IMT = 0.96 mm. The axial 3DUS image of the common carotid artery 
shows the intima-lumen boundary in green and carotid plaque-lumen boundary in yellow. The longitudinal 3DUS carotid image shows IMT segmentation of the common 
carotid artery.
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(21) and never-smokers with second-hand smoke 
exposure (23). Our finding of abnormal 3He ventila-
tion in the absence of abnormal DLCO, ADC or CT 
RA950 in ex-smokers is in agreement with the notion 
that “silent” airway disease (20) and small airway 
remodeling (52) may be the source of ventilation 
defects in these subjects. 
We think that the signiﬁ cant diﬀ erences observed 
for VDP in the absence of diﬀ erences in DLCO, ADC or 
RA950 suggests mild, sub-clinical airway abnormalities, 
although we must point out that a deﬁ nitive structure-
function etiology for 3He ventilation defects (46, 53, 54) 
is yet to be determined. It is also worth noting that for 
the healthy ex-smokers evaluated here, there was no CT 
Figure 2. Imaging phenotypes in asymptomatic ex-smokers and never-smokers. Ex-smokers have signiﬁ cantly greater: A) TPV (p = 0.002) and D) VDP (p = 0.001) than 
never-smokers. No signiﬁ cant differences were observed for: B) IMT (p = 0.11), C) VWV (p = 1.0), or E) ADC (p = 0.20). Holm-Bonferroni corrected p values are shown.
Figure 3. Comparisons between never- and ex-smokers with IMT ≥ age-related upper limit of normal (IMT >97.5% conﬁ dence interval (CI)) and subjects with IMT < 
age-related normal limit (IMT ≤ 97.5 CI). A) Subjects with abnormally elevated IMT have statistically signiﬁ cantly different VDP (p = 0.04) than subjects with normal IMT. 
No signiﬁ cant differences were observed for: B) ADC (p = 0.06), C) FEV1 (p = 1.0) or D) DLCO (p = 0.85). Comparisons displayed are Holm–Bonferroni corrected p values.
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evidence of emphysema or airways disease and such 
values were in agreement with those reported in healthy 
non-smokers in the COPDGene study (49, 50). Th is 
ﬁ nding underscores the sensitivity of 3He MRI ventila-
tion measurements for detecting functional abnormali-
ties that may not be apparent using CT or spirometry. 
Previous work in COPD patients (3, 4, 6, 7, 17, 55, 56) 
reported a relationship for IMT with FEV1 and emphy-
sema measurements, but this was not observed here in 
ex-smokers without COPD. We were likely underpow-
ered to detect diﬀ erences in IMT between subgroups as 
these previous studies investigating IMT in COPD and 
healthy older subjects used sample sizes ranging from 
305 to 14,480 subjects. On the other hand, signiﬁ cantly 
elevated 3DUS TPV in the ex-smoker subgroup was 
consistent with previous work (35, 36) that showed 
smaller sample sizes can be used when employing 3D 
measurements of plaque as compared to IMT. Although 
no diﬀ erence was observed for IMT between ex- and 
never-smokers, when age-normalized IMT values were 
used to stratify subjects (51), subjects with abnormal 
IMT had signiﬁ cantly worse VDP. Th is ﬁ nding suggests 
that in both never- and ex-smokers with elevated IMT, 
there is evidence of mild, subclinical airways disease that 
may be related to factors other than cigarette smoking. 
We also observed signiﬁ cant univariate relation-
ships for 3He VDP with carotid artery IMT, TPV and 
VWV, consistent with previous studies that showed 
relationships between spirometry measurements 
and carotid IMT (3, 4, 6, 17, 55, 56), although this is 
the ﬁ rst report of such relationships in subjects with 
normal pulmonary function. Similarly, multivariate 
regression models that controlled for cardiovascular 
and pulmonary disease risk factors showed that VDP 
is a signiﬁ cant predictor of carotid artery IMT, VWV 
and TPV. It is also important to note that carotid TPV 
and VWV provide measurements of intima echogenic 
(TPV and VWV) and echolucent (VWV) plaque (38, 
57, 58). Hence, these relationships between VDP and 
IMT, VWV and TPV suggest that in this relatively 
small group of never- and ex-smokers, mild, subclini-
cal airways disease may be related to carotid plaque 
burden and wall thickening.
Although it was recently shown that COPD patients 
may have atherosclerotic plaque characteristics that 
make them more vulnerable to rupture (6), we did not 
evaluate carotid plaque composition here. Th e sig-
niﬁ cant carotid plaque burden quantiﬁ ed in some of 
the ex-smokers investigated here may be amenable to 
more complex image methods (59) to develop a better 
understanding of plaque composition/texture and out-
comes. We acknowledge that the main limitation of this 
study was the relatively small sample size of never- and 
ex-smokers, and that this may have limited our power 
to detect any potential diﬀ erences in IMT and FEV1 
between subgroups. 
Certainly, one of the strengths of 3D imaging is that 
signiﬁ cantly diﬀ erent measurements can be detected in 
Table 2. Multiple regression models for IMT, VWV and TPV
IMT VWV TPV
β 
coefﬁ cient
p 
value
β 
coefﬁ cient
p 
value
β 
coefﬁ cient
p 
value
Age 0.32 0.02 –0.08 0.63 0.18 0.20
BMI 0.20 0.11 –0.11 0.44 0.09 0.47
FEV1 –0.03 0.81 0.21 0.18 0.10 0.48
DLCO 0.15 0.22
−0.08 0.59 −0.10 0.46
VDP 0.41 0.001 0.45 0.003 0.38 0.005
Dependent Variables: IMT, r2 = 0.27, p = 0.001; VWV, r2 = 0.21, p = 0.08; TPV, r2 = 0.16, p = 0.02.
Figure 4. Relationships for carotid atherosclerosis and pulmonary VDP. Signiﬁ cant 
relationships between 3He MRI VDP and: A) carotid IMT (r = 0.42, p = 0.004), B) TPV 
(r = 0.41, p = 0.006), and, C) VWV (r = 0.40, p = 0.007).
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small groups of subjects, because of the high dynamic 
range and sensitivity of 3D measurements to structure-
function abnormalities. Th is is an important consid-
eration when powering studies to detect diﬀ erences 
in small groups of subjects. Finally, we cannot infer 
the temporal or causal nature of carotid and pulmo-
nary abnormalities in this cross-sectional evaluation. 
Questions related to “which came ﬁ rst” still need to be 
answered in longitudinal natural disease and interven-
tion studies (60). 
In conclusion, we acquired sensitive 3D imaging 
measurements of atherosclerosis and pulmonary struc-
ture-function in order to illuminate potential relation-
ships between early or mild sub-clinical pulmonary 
disease with atherosclerosis in otherwise healthy ex-
smokers. Although a number of studies have provided 
evidence that pulmonary and carotid abnormalities are 
both present and related in COPD patients, here, this 
important relationship was shown in never- and ex-
smokers with normal pulmonary function. Although 
the clinical relevance of these observations is not yet 
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carotid atherosclerosis in never- and ex-smokers with-
out airﬂ ow limitation may be directly related. As our 
knowledge of co-morbid lung and vascular disease 
increases, such ﬁ ndings may potentially have implica-
tions for patient management decision strategies in 
preclinical stages.
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